General Catalyst, a venture capital firm that makes early-stage and transformational investments, led a $500m Series D funding round in Ro, a healthcare technology firm building a patient-centric healthcare system, with participation from investors FirstMark Capital, TQ Ventures, Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776. "The current healthcare system is working beautifully for insurance companies, but terribly for patients; to pretend otherwise is absolutely ridiculous. It's time to give patients power. Ro is the only company to combine a nationwide telemedicine, pharmacy distribution, and in-home care network. Through this vertically integrated platform we're making high-quality care available when and where patients need it, with no insurance required so patients are the ones in control. We're powering a patient revolution, and we're just getting started," Zachariah Reitano, Ro Co-Founder & CEO.